insights_auto
Why is NWBO up 6.04%?
Dive Deeperchevron_right
NWBO:OTCMKTS
Northwest Biotherapeutics Inc
$0.16
arrow_upward
+6.04%(+0.0094) 1D
Oct 20, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NWBO...
Open
$0.16
High
$0.17
Low
$0.15
Mkt. cap
272.04M
Avg. vol.
4.21M
Volume
5.90M
52-wk high
$0.34
52-wk low
$0.14
EPS
-$0.03
Beta
-0.62
Shares outstanding
1.71B
No. of employees
105
Open
$0.16
High
$0.17
Low
$0.15
Mkt. cap
272.04M
Avg. vol.
4.21M
Volume
5.90M
52-wk high
$0.34
52-wk low
$0.14
EPS
-$0.03
Beta
-0.62
Shares outstanding
1.71B
No. of employees
105
News stories
From web sources and news partners
BigGo Finance
·
9 minutes ago
Dow Up 1%, Nasdaq Flat: Wall Street Turns From AI Stocks to Earnings and Balance Sheets
marketscreener.com
·
20 minutes ago
Communications Services Down Ahead of Netflix Earnings - Communications Services Roundup
ChartMill
·
58 minutes ago
S&P 500 After-Hours Movers: Oct. 20 Gainers and Decliners
Devdiscourse
·
49 minutes ago
US STOCKS-Dow outperforms as Wall Street rises, healthcare stocks lead gains
Profile
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
About Northwest Biotherapeutics Inc